361 Capital’s Kellanova K Stock Holding History

361 Capital’s Portfolio K Stock Details K Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-12,926	Closed	-$757K	–	270
2017 Q3	$757K	Buy	+12,926	New	+$816K	0.15%	218

Other funds holding K

WKKFT

W.K. Kellogg Foundation Trust Battle Creek, Michigan $3.7B AUM 1.51% 1-Year Est. Return

KeyBank National Association Cleveland, Ohio $27.4B AUM 24.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

AIG

American International Group New York $609M AUM 23.67% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

361 Capital's K Position: Q4 2017 in Review

361 Capital sold out of Kellanova (K) in Q4 2017, closing a stake of 12,926 shares — an estimated $757K sold.

361 Capital first reported a position in K in Q3 2017 and held it in 1 quarter. The position peaked at $757K in Q3 2017. 709 funds tracked by Wall St. Rank hold K as of Q4 2017.

361 Capital reported no remaining Kellanova position as of Q4 2017 after selling out during the quarter.
361 Capital sold 12,926 Kellanova shares in Q4 2017, an estimated $757K.
361 Capital first reported a position in Kellanova in Q3 2017 and held it in 1 quarter.
361 Capital's Kellanova position peaked at $757K in Q3 2017.
709 funds tracked by Wall St. Rank held Kellanova as of Q4 2017.

Based on 361 Capital's 13F filing for Q4 2017, filed 14 Feb 2018.